The Talk


Leukemia: A Review of Data from the ASCO and EHA 2023 Meetings

August 18th 2023

A panel of experts discusses key datasets in leukemia that were presented recently at the American Society of Clinical Oncology [ASCO] 2023 Annual Meeting and the European Hematology Association [EHA] 2023 Congress.

Lower-Risk MDS: A Review of Data from the ASH 2022 Annual Meeting

February 23rd 2023

Experts in hematologic oncology give an overview of first- and second-line MDS treatment options, and discuss updates from the ASH 2022 Annual Meeting.

Leukemia: A Review of Data from the ASH 2022 Meeting

December 22nd 2022

Expert hematologist/oncologists review key datasets in leukemia presented at the ASH 2022 Annual Meeting.

Supported in part by Amgen Oncology, Servier, and Takeda Oncology. Content developed independently by OncLive®.

Leukemia & Lymphoma: A Review of Data from the ASCO 2022 and EHA 2022 Meetings

July 13th 2022

Expert oncologists review key datasets in leukemia & lymphoma that were presented at the ASCO 2022 and EHA 2022 Annual Meetings.

Leukemia: A Review of Data from the ASH 2021 Meeting

January 31st 2022

Expert hematologist/oncologists come together to review key datasets in leukemia that were presented at the ASH 2021 Annual Meeting.

Sponsored in part by Takeda. Content independently developed by OncLive®


HER2-Positive Breast Cancer: A Review of Data from the SABCS 2021 Virtual Meeting

December 23rd 2021

Virginia Kaklamani, MD, DSc, shares her excitement for an upcoming OncLive® "The TALK" program focusing on HER2-positive breast cancer updates from the SABCS 2021 Virtual Meeting.

THE TALK: Breast Cancer, A Review of Data from the SABCS 2021 Virtual Meeting

December 20th 2021

Sara A. Hurvitz, MD; Aditya Bardia, MD, MPH; Patrick Neven, MD, PhD; and Kevin Kalinsky, MD, MS, review recent updates and data in breast cancer presented at the SABCS 2021 Virtual Meeting.

THE TALK: Gastrointestinal Cancers A Review of Data from the ESMO 2021 Virtual Meeting

November 15th 2021

Experts in gastric cancers review recent updates and data in gastrointestinal cancers presented at the ESMO 2021 Virtual Meeting.

Sponsored in part by Daiichi Sankyo. Content independently developed by OncLive.

THE TALK: Breast Cancer

October 25th 2021

Experts in breast oncology gather for a discussion on important datasets in breast cancer recently presented at the ESMO 2021 Virtual Meeting.

Sponsored in part by Daiichi Sankyo. Content independently developed by OncLive.

2021 ASCO Virtual Meeting: Leukemia TALK

July 8th 2021

Expert perspectives on trial designs, study populations, safety/efficacy results, and practical implications from the 2021 ASCO (American Society of Clinical Oncology) and EHA (The European Hematology Association).

Funding from Amgen Oncology and Takeda Oncology/Content Developed Independently by OncLive

Lung Cancer TALK: A Review of Data from the IASLC 2020 World Conference on Lung Cancer

February 26th 2021

“Multiple Myeloma Talk”: A Review of Data from the ASH 2020 Virtual Meeting

January 29th 2021

“Breast Cancer Talk” Review of Data from the SABCS 2020 Virtual Meeting

January 27th 2021

“HER2 Breast Cancer Talk”: A Review of Data from the SABCS 2020 Virtual Symposium

January 25th 2021

Hematologic Malignancies Talk: Exciting Updates from ASH 2020 Virtual Meeting

January 22nd 2021

“Breast Cancer Talk”: Nursing Perspectives on HER2-Targeted Agents in Breast Cancer

September 23rd 2020

“Breast Cancer Talk” Contemporary Concepts: Systemic Therapy for Breast Cancer

September 16th 2020

“Lung Cancer Talk”: A Review of Data from the ASCO 2020 Virtual Meeting

September 1st 2020

Review of Data from the ASCO 2020 Virtual Meeting

August 13th 2020

“GI Talk”: A Review of Data from the ASCO 2020 Virtual Meeting

August 10th 2020